ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Tokyo Electron Ltd (PK)

Tokyo Electron Ltd (PK) (TOELY)

71.355
2.08
( 3.00% )
Actualizado: 13:27:05

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
71.355
Postura de Compra
71.22
Postura de Venta
71.40
Volume Operado de la Acción
130,769
70.10 Rango del Día 73.29
68.83 Rango de 52 semanas 134.91
Capitalización de Mercado [m]
Precio Anterior
69.28
Precio de Apertura
71.00
Última hora de negociación
13:27:58
Volumen financiero
US$ 9,276,723
Precio Promedio Ponderado
70.9398
Volumen promedio (3 m)
166,648
Acciones en circulación
943,265,466
Rendimiento del Dividendo
1.81%
Ratio Precio/Utilidad
0.36
Beneficio por acción (BPA)
385.85
turnover
1.83T
Beneficio neto
363.96B

Acerca de Tokyo Electron Ltd (PK)

Sector
Fabricated Plate Work
Industria
Semiconductors
Sitio web
Sede
Minato, Tokyo, Jpn
Fundado
1985
Tokyo Electron Ltd (PK) is listed in the Fabricated Plate Work sector of the OTCMarkets with ticker TOELY. The last closing price for Tokyo Electron (PK) was US$69.28. Over the last year, Tokyo Electron (PK) shares have traded in a share price range of US$ 68.83 to US$ 134.91.

Tokyo Electron (PK) currently has 943,265,466 shares in issue. The market capitalisation of Tokyo Electron (PK) is US$65.35 billion. Tokyo Electron (PK) has a price to earnings ratio (PE ratio) of 0.36.

TOELY Últimas noticias

OTC Markets Group Announces First Quarter 2015 Performance of OTCQX and OTCQB Indexes, OTCM ADR Index and OTCQX30 Index and Q...

OTC Markets Group Announces First Quarter 2015 Performance of OTCQX and OTCQB Indexes, OTCM ADR Index and OTCQX30 Index and Quarterly Rebalancing PR Newswire NEW YORK, April 16, 2015 NEW YORK...

OTC Markets Group Announces Third Quarter 2014 Performance of OTCM ADR Index and OTCQX30 Index, powered by BNY Mellon Indices...

OTC Markets Group Announces Third Quarter 2014 Performance of OTCM ADR Index and OTCQX30 Index, powered by BNY Mellon Indices(SM) PR Newswire NEW YORK, Oct. 27, 2014 NEW YORK, Oct. 27, 2014...

OTC Markets Group Announces First Quarter 2014 Performance of OTCM ADR Index

OTC Markets Group Announces First Quarter 2014 Performance of OTCM ADR Index PR Newswire NEW YORK, April 28, 2014 NEW YORK, April 28, 2014 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM...

OTCM ADR Index Rose 5.3% in Fourth Quarter, 18.7% for Full Year 2013

OTCM ADR Index Rose 5.3% in Fourth Quarter, 18.7% for Full Year 2013 PR Newswire NEW YORK, March 4, 2014 NEW YORK, March 4, 2014 /PRNewswire/ -- The OTCM ADR Index powered by BNY Mellon DR...

Applied Materials and Tokyo Electron to Combine, Creating a New Global Innovator to Serve the Semiconductor and Display Indus...

Applied Materials and Tokyo Electron to Combine, Creating a New Global Innovator to Serve the Semiconductor and Display Industries - All-stock transaction creating a new company as a merger of...

Tokyo Electron Limited Completes Acquisition of FSI International, Inc.

Tokyo Electron Limited Completes Acquisition of FSI International, Inc. PR Newswire TOKYO, Oct. 11, 2012 TOKYO, Oct. 11, 2012 /PRNewswire/ -- Tokyo Electron Limited ("Tokyo Electron";...

Tokyo Electron Limited Announces Completion of Tender Offer for FSI International, Inc.

Tokyo Electron Limited Announces Completion of Tender Offer for FSI International, Inc. PR Newswire TOKYO, Oct. 11, 2012 TOKYO, Oct. 11, 2012 /PRNewswire/ -- Tokyo Electron Limited ("Tokyo...

Tokyo Electron Limited Extends Tender Offer to Acquire FSI International, Inc.

Tokyo Electron Limited Extends Tender Offer to Acquire FSI International, Inc. PR Newswire TOKYO, Sept. 25, 2012 TOKYO, Sept. 25, 2012 /PRNewswire/ -- Tokyo Electron Limited ("Tokyo Electron";...

Tokyo Electron Limited Commences Previously Announced Tender Offer to Acquire FSI International, Inc.

Tokyo Electron Limited Commences Previously Announced Tender Offer to Acquire FSI International, Inc. PR Newswire TOKYO, Aug. 27, 2012 TOKYO, Aug. 27, 2012 /PRNewswire/ -- Tokyo Electron Limited...

SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the ...

SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of FSI International, Inc. in Connection with the Sale of the...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.845-1.170360110872.273.2968.8319502770.33398162DR
4-3.145-4.2214765100774.580.1668.8316958274.46304566DR
12-17.845-20.005605381289.29368.8316664880.6300697DR
26-42.3651-37.253836393113.7201120.168.8314294490.84640745DR
52-9.645-11.907407407481134.9168.83164538100.85813799DR
156-20.80812212-22.577492647192.16312212134.9138.871112912677380.07630551DR
26038.03499923114.15065531533.32000077134.9124.270288569855574.23620271DR

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AGDXFAntioqua Gold Inc (CE)
US$ 0.02
(1,999,900.00%)
2.5k
ISUNQiSun Inc (CE)
US$ 0.0007
(69,900.00%)
19.21k
TTCFQTattooed Chef Inc (CE)
US$ 0.0002
(19,900.00%)
51.12k
YAYOYayYo Inc (CE)
US$ 0.0001
(9,900.00%)
2.83k
ECPNEl Capitan Precious Metals Inc (CE)
US$ 0.0001
(9,900.00%)
2.25k
EGBBEarth Gen Biofuel Inc (CE)
US$ 0.000001
(-99.95%)
8k
CNVIFConavi Medical Corporation (PK)
US$ 0.0007
(-99.88%)
1.93k
SPRNSupernova Energy Inc (CE)
US$ 0.000001
(-99.67%)
2k
SCNGSC Holdings Corporation (CE)
US$ 0.000001
(-99.50%)
55k
FUNFFFansUnite Entertainment Inc (CE)
US$ 0.000001
(-99.50%)
2.4k
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0001
(0.00%)
210.2M
HCMCHealthier Choices Management Corporation (PK)
US$ 0.00005
(4,900.00%)
115.06M
THBDThird Bench Inc (PK)
US$ 0.0003
(200.00%)
112.63M
QEDNQED Connect Inc (PK)
US$ 0.0005
(25.00%)
78.09M
RDARRaadr Inc (PK)
US$ 0.0007
(16.67%)
70.75M
manibiotech manibiotech 48 segundos hace
However the data of current trial submitted for approval is not "in vitro"
NWBO
payupdeadbeat payupdeadbeat 49 segundos hace
It is clear that the "investment of a lifetime* message is not getting out. I hope the longs are not being hornscwaggled.
ZHUD
Craig305 Craig305 1 minuto hace
This is the highest day volume since June 2022. 
AVVH
Serpico2005 Serpico2005 1 minuto hace
HUGE revenue pouring in here, we won't be denied, won't be able the hold it down much longer. 
SPZI
delerious1 delerious1 1 minuto hace
Milling results soon yet some say that this stock is garbage etc have been here as long as me or longer so that would mean plenty of time to see the patterns and make some really good money....but I bet that they haven't....so it is a bit of a conundrum....why wouldn't they when obviously given the
NBRI
ExtremelyBullishZig ExtremelyBullishZig 1 minuto hace
No...all biotechs are up based on gene editing company success it move the index 
AVXL
richme richme 2 minutos hace
Need to Curb Your Enthusiasm just because the share price jumped all the way to $0.0166 share price,
-$0.0015 day change. Isn't that great? We will be heading to Mars soon....no less in Elon Musk's rocket ship or to hell in ________ (add your own).
ZHUD
Quintessence Quintessence 2 minutos hace
PDYNW - Nice move today! I will consider buying dips.
JRoon71 JRoon71 2 minutos hace
TC, I get that. I just meant that in looking at what Italy pays for other drugs, what Amarin wants for Vazkepa is substantially more than MOST drugs on the list.

I'm not talking about the cost to patients, but the cost to the government.

If Vazkepa cost $15 to sell to
AMRN
dennisdave dennisdave 3 minutos hace
BTW, the three companies with approved PD1 inhibitors, which is what the U.S. patent office tried to narrow the combo patent to, are:

Merck = Keytruda

Opdivo = Bristol

Libtayo = Regeneron.
Thanks very helpful.
NWBO
attilathehunt attilathehunt 3 minutos hace
1 buy of 20k will work the same as 2 buys of 10k on squeeze day, no?

NO!!!!!

On squeeze day your first buy order will be much much lower than all subsequent ones...

For example, on Squeeze day (approval) if your first early open trade gets executed at 1.0
NWBO
bgATL bgATL 3 minutos hace
Gaetz is out, my opinion has been he was never really going to be in the position, as it was cover to let him resign from the House before the severe reprimands which could have ruined his chances of a future career. Trump also could now argue he tried to put a pot friendly guy in the office and it
TCNNF
Pic Pic 3 minutos hace
I wonder if .0011 is a good entry? Fishing time. 🎣
AFFU
konshe konshe 3 minutos hace
Strong buy at ask 0.0002, paint sell at bid 0.0001. 0.0002 2mm shares will be gone soon.
TPTW
al44 al44 3 minutos hace
The world will become safer when the ‘adults in the room’ are… gone

By Jack Hellner


When Biden and his team of incompetents took over, the media cheered that finally the adults were back in the room; well thankfully, the “children” will be back soon and the U.S.
Real McCoy Real McCoy 3 minutos hace
I think they think that announced participation in a hot industry segment should entitle them to valuation levels of those hot industry segment leaders. Despite ALWAYS having virtually no revenue.
VERB
KRISGO KRISGO 3 minutos hace
Hello Dcaf7, based on the full abstract being released on Nov 25th, can the experts evaluate whether same-day dosing is effective and works better?
ASRT
PennyMillions852 PennyMillions852 3 minutos hace
BID building here but...you KNOW what will come next......this is the type of chit that needs to stop for us to move up above .0003!
THBD
Hitman970 Hitman970 3 minutos hace
Why hasn't this historic moment made any mainstream press?
x / twitter and company generate PRs mean nothing.
You are repeating yourself over and over. Do you know Vic? You called him "benign" a while back.
BNCM
CrashOverride CrashOverride 4 minutos hace
If it was DCVax the 2016 paper would cite Liau or Prins as they are the leaders in the field of Dendritic-cell-based vaccines.

They had several papers published before 2016.

It doesn't so it isn't DCVax.
NWBO
biotechinvestor1 biotechinvestor1 4 minutos hace
From another poster: “Evotec has already said no thanks. Wall Street said no thanks. When Halozyme management says ok forget about it, we go up $10. We are waiting Ms Helen.”
HALO
BamaBreeze BamaBreeze 4 minutos hace
Can you bring in the update your referencing(please).
BLLB
redspinelpinktopaz redspinelpinktopaz 4 minutos hace
No. It seems all right to me.
LWLG
glenn1919 glenn1919 4 minutos hace
TRNR....CISO....MULN.........................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134
CISO MULN TRNR
WinstonCup WinstonCup 4 minutos hace
Sometimes you make no sense.
WDLF